Chief Physician, MD, PhD Supervisor, Administrative Director of Thoracic Surgery and Executive Director of the Lung Transplantation Center at Shanghai Pulmonary Hospital
Affiliated HospitalShanghai Pulmonary Hospital (Shanghai Pulmonary Hospital Affiliated to Tongji University)
→
Member of the Mediastinal Tumor Committee of the Chinese Anti-Cancer Association. He conducted visiting research at the Mayo Clinic in the United States from 2006 to 2007. He was among the first in China to perform large-scale robot-assisted single-port lung resection and subxiphoid thymectomy, reducing the conventional robot-assisted lung resection from 4 or 5 ports to single-port and single-port procedures. In February 2021, he performed the world's first single-port robotic sleeve lobectomy. He has completed over 800 robot-assisted surgeries, with an individual annual surgical volume of over 1500 cases, placing him among the leading thoracic surgeons in China. In 2025, the department's number of surgeries assisted by the domestically produced Tomahawk robot officially exceeded 1000, marking the first time a domestically produced surgical robot has achieved 1000 clinical applications in a single center and specialty. The team, in collaboration with 20 medical centers in China, jointly developed technical specifications and consensus for multi-arm single-port robotic surgery. He was awarded the "Shanghai Good Person" award in 2025. Specializes in mediastinal tumors, thymic tumors, early and mid-to-late stage lung cancer, and pulmonary nodules.